Cargando…
Targeting DCLK1 overcomes 5‐fluorouracil resistance in colorectal cancer through inhibiting CCAR1/β‐catenin pathway‐mediated cancer stemness
BACKGROUND: To date, 5‐fluorouracil‐based chemotherapy is very important for locally advanced or metastatic colorectal cancer (CRC). However, chemotherapy resistance results in tumor recurrence and metastasis, which is a major obstacle for treatment of CRC. METHODS: In the current research, we estab...
Autores principales: | Wang, Lanqing, Zhao, Lei, Lin, Zhenyu, Yu, Dandan, Jin, Min, Zhou, Pengfei, Ren, Jinghua, Cheng, Jing, Yang, Kunyu, Wu, Gang, Zhang, Tao, Zhang, Dejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076011/ https://www.ncbi.nlm.nih.gov/pubmed/35522902 http://dx.doi.org/10.1002/ctm2.743 |
Ejemplares similares
-
CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway
por: Xu, Guojie, et al.
Publicado: (2023) -
Analysis of the clinical significance of DCLK1(+) colorectal cancer using novel monoclonal antibodies against DCLK1
por: Dai, Tianqi, et al.
Publicado: (2018) -
DCLK1 immunoreactivity in colorectal neoplasia
por: Gagliardi, Giuseppe, et al.
Publicado: (2012) -
Inhibition of CCAR1, a Coactivator of β-Catenin, Suppresses the Proliferation and Migration of Gastric Cancer Cells
por: Chang, Te-Sheng, et al.
Publicado: (2017) -
DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
por: Mohammadi, Chiman, et al.
Publicado: (2021)